- Stocks
- Healthcare
- NASDAQ: KRMD

Price (delayed)

$4.18

Market cap

$185.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.07

Enterprise value

$159.4M

KRMD's debt has dropped by 89% year-on-year and by 15% since the previous quarter

The company's equity rose by 4.5% QoQ

The quick ratio has soared by 164% YoY but it has contracted by 18% from the previous quarter

The net income has dropped by 142% since the previous quarter

KRMD's EPS has dropped by 133% since the previous quarter

What are the main financial stats of KRMD

Market
Valuations
Earnings

Shares outstanding

44.49M

Market cap

$185.97M

Enterprise value

$159.4M

Price to earnings (P/E)

N/A

Price to book (P/B)

4.92

Price to sales (P/S)

7.89

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.85

Revenue

$23.28M

EBIT

-$4M

EBITDA

-$3.56M

Free cash flow

-$4.38M

Per share
Balance sheet
Liquidity

EPS

-$0.07

Free cash flow per share

-$0.1

Book value per share

$0.85

Revenue per share

$0.53

TBVPS

$0.94

Total assets

$42.37M

Total liabilities

$4.59M

Debt

$203,441

Equity

$37.78M

Working capital

$34.55M

Debt to equity

0.01

Current ratio

8.63

Quick ratio

6.7

Net debt/EBITDA

7.47

Margins
Efficiency
Dividend

EBITDA margin

-15.3%

Gross margin

61.8%

Net margin

-12.6%

Operating margin

-17.4%

Return on assets

-6.7%

Return on equity

-7.7%

Return on invested capital

-53.5%

Return on capital employed

-10.6%

Return on sales

-17.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Repro Med Systems stock price performed over time

Intraday

-3.02%

1 week

-7.93%

1 month

0%

1 year

-59.14%

YTD

-30.56%

QTD

18.75%

How have Repro Med Systems's revenue and profit performed over time

Revenue

$23.28M

Gross profit

$14.38M

Operating income

-$4.05M

Net income

-$2.94M

Gross margin

61.8%

Net margin

-12.6%

KRMD's net margin has dropped by 152% since the previous quarter

The net income has dropped by 142% since the previous quarter

The gross profit has declined by 8% year-on-year and by 3.7% since the previous quarter

The revenue has contracted by 5% YoY and by 3.7% from the previous quarter

What is Repro Med Systems's growth rate over time

What is Repro Med Systems stock price valuation

P/E

N/A

P/B

4.92

P/S

7.89

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.85

KRMD's EPS has dropped by 133% since the previous quarter

KRMD's price to book (P/B) is 43% lower than its 5-year quarterly average of 8.7 and 31% lower than its last 4 quarters average of 7.1

The company's equity rose by 4.5% QoQ

The P/S is 26% below the last 4 quarters average of 10.7 but 25% above the 5-year quarterly average of 6.3

The revenue has contracted by 5% YoY and by 3.7% from the previous quarter

How efficient is Repro Med Systems business performance

Repro Med Systems's return on assets has shrunk by 185% YoY and by 109% QoQ

KRMD's return on invested capital has dropped by 185% since the previous quarter

Repro Med Systems's ROE has plunged by 177% YoY and by 103% from the previous quarter

What is KRMD's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for KRMD.

How did Repro Med Systems financials performed over time

The quick ratio has soared by 164% YoY but it has contracted by 18% from the previous quarter

The total assets has soared by 155% YoY and by 6% from the previous quarter

KRMD's debt is 99% smaller than its equity

The debt to equity has shrunk by 93% YoY

KRMD's debt has dropped by 89% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.